Prof. Gribben's highlights from ASH 2016
The use of venetoclax (ABT-199) in the treatment of CLL
How to address the issue of access to new drugs in multiple myeloma
Paul Richardson et al.
Research on HDACs for multiple myeloma: studying immunological effects and resistance models